AYERST PLANNING ON FIRST QUARTER 1986 NDA SUBMISSION FOR ALREDASE (TOLRESTAT) IN DIABETIC NEUROPATHY; FIRM IS SHOOTING FOR EARLY 1987 MARKET LAUNCH

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".